Technology

Biolase

$0.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0811 (-8.87%) Today
+$0.007 (+0.84%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Biolase and other stocks, options, and ETFs commission-free!

About BIOL

Biolase, Inc. Common Stock, also called Biolase, is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA. The listed name for BIOL is Biolase, Inc. Common Stock.

CEO
Todd A. Norbe
Employees
157
Headquarters
Irvine, California
Founded
1987
Market Cap
78.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
80.26M
High Today
$0.884
Low Today
$0.801
Open Price
$0.883
Volume
36.57M
52 Week High
$1.38
52 Week Low
$0.211

Collections

BIOL Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, After Hours

You May Also Like

BMA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure